Blog
Blogs from AHA leaders and members on the latest health care issues.
Even as we work to close our knowledge gaps around long-term outcomes and care, it is clear that Neonatal Abstinence Syndrome merits greater attention.
CHW programs — which are in wider use overseas than domestically — hold enormous promise for delivering on hospitals’ commitment to advance health in their communities.
Every day, more than 130 Americans die from opioid-related drug overdoses. It’s clear that the opioid epidemic’s grip on our communities continues to be a major challenge. At the same time, we also see progress in addressing the problem.
AHA Chief Medical Officer Jay Bhatt, D.O., shares examples of how Avera Health in South Dakota, WellSpan York Hospital in Pennsylvania, and the University of Alabama at Birmingham Health System are implementing efforts to advance clinician well-being and reduce burnout. Read more.
Wendy Macias-Konstantopoulos, M.D., director of Massachusetts General Hospital’s Human Trafficking Initiative, shares how clinicians are key to stopping the cycle of human trafficking, and how new ICD-10 codes that went into effect Oct. 1 can help.
Join me in taking the CDC AMR Challenge to tackle the pressing issue of antimicrobial resistance in order to ensure a holistic, multidisciplinary approach in combatting AMR at the regional and national levels.
In times of distress, Americans turn to hospital emergency departments. They do so because they know that there they will find care – from simple stitches to sophisticated diagnostics to emergency surgery. And they know that, no matter what, they will not be turned away.
AHA Chief Medical Officer Jay Bhatt, D.O. highlights two podcasts from the AHA Physician Alliance series in which Allen Weiss, M.D., president and CEO of NCH Healthcare System in Naples, Fla., and Christine Stabler, M.D., vice president for academic affairs, Lancaster Health in Lancaster, Pa.,…
The Pharmaceutical Research and Manufacturers of America (PhRMA) released yet another “report” in an obvious attempt to divert attention away from a problem of their own making: skyrocketing drug prices.
A recent article in the New York Times, “A Little-Known Windfall for Some Hospitals, Now Facing Big Cuts,” gives a thoroughly inaccurate and misleading view of the 340B Drug Pricing Program.